Harborside Press

SHERPA: Unknown

People

  1. Saltz
    Saltz
  2. Zelenetz
    Zelenetz
  3. Yahalom
    Yahalom
  4. Abu-Rustum
    Abu-Rustum
  5. Riely
    Riely
  6. Sofocleous
    Sofocleous
  7. Shah
    Shah
  8. Pfister
    Pfister
  9. Motzer
    Motzer
  10. McCormick
    McCormick

Groups

  1. Department of Medicine (412)
  2. Solid Tumor Oncology Division (244)
  3. Surgery (172)
  4. Survivorship Research (139)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)
  7. Population Sciences Research Program (102)
  8. Division of Subspecialty Medicine (77)
  9. Gastrointestinal Oncology Service (74)
  10. Radiation Oncology, Department of (72)
Search Within
Formats
  1. Journal Article (480)
  2. Guidelines (156)
  3. Review (38)
  4. Editorial (17)
  5. Conference Paper (10)
  6. Meeting Abstract (7)
  7. Correspondence (2)
Groups
  1. Department of Medicine (412)
  2. Solid Tumor Oncology Division (244)
  3. Surgery (172)
  4. Survivorship Research (139)
  5. Hematologic Malignancies, Division of (122)
  6. Center for Hematologic Malignancies (111)

More Groups

People
  1. Leonard Saltz (42)
  2. Andrew Zelenetz (35)
  3. Joachim Yahalom (31)
  4. Gregory Riely (27)
  5. Nadeem Abu-Rustum (27)
  6. Constantinos Sofocleous (22)

More People

Years
  1. 2025 (29)
  2. 2024 (38)
  3. 2023 (32)
  4. 2022 (43)
  5. 2021 (46)
  6. 2020 (35)

More Years

Publications
  1. Journal of the National Comprehensive Cancer Network (686)
  2. Journal of the Advanced Practitioner in Oncology (23)
  3. The ASCO Post (1)

Results (710)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Histologic-and genomic-directed adjuvant therapy for ampullary adenocarcinoma: A hidden genome–derived analysis
    Journal Article

    Ecker, B. L.; Seier, K.; Choubey, A.; Eckhoff, A. M.; Tortorello, G. N.; Balachandran, V. P.; Blackburn, N.; D’Angelica, M. I.; DeMatteo, R. P.; Blazer, D. G. 3rd; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Thymomas and thymic carcinomas, version 2.2025
    Guidelines

    Riely, G. J.; Wood, D. E.; Loo, B. W. Jr; Aisner, D. L.; Akerley, W.; Bauman, J. R.; Bharat, A.; Chang, J. Y.; Chirieac, L. R.; DeCamp, M.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Artificial intelligence in cancer care: Opportunities, challenges, and governance
    Review

    Chornenky, D.; Haddad, T. C.; Stetson, P. D.; Goodman, C. S.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Multiple myeloma, version 1.2025 featured updates to the NCCN guidelines®
    Guidelines

    Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L. D. Jr; Baljevic, M.; Baz, R.; Campagnaro, E.; Costello, C.; D’Angelo, C.; Derman, B.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Gastric cancer, version 2.2025
    Guidelines

    Ajani, J. A.; D’Amico, T. A.; Bentrem, D. J.; Corvera, C. U.; Das, P.; Enzinger, P. C.; Enzler, T.; Gerdes, H.; Gibson, M. K.; Grierson, P.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Management and outcomes of clostridioides difficile infection in patients on immune checkpoint inhibitors
    Journal Article

    Magahis, P. T.; Satish, D.; Kamboj, M.; Babady, N. E.; Baul, J.; Kalvin, H. L.; Panageas, K.; Postow, M. A.; Laszkowska, M.; Faleck, D. M.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • HSR25-180: Real-world (rw) characteristics, treatment (tx) patterns and clinical outcomes in patients (pts) with limited-stage small-cell lung cancer (LS-SCLC) who received chemoradiotherapy (CRT)
    Meeting Abstract

    Iyengar, P.; Kahangire, D. A.; Wang, A.; Hsieh, K.; Donner, N.; Syed, I.; Simmons, D.; Chiang, A. C.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • TIP25-243: Randomized study evaluating optimal dose, efficacy and safety of E7386 + lenvatinib versus treatment of physicians' choice in advance/recurrent endometrial carcinoma previously treated with anti-PD-(L)1 immunotherapy
    Meeting Abstract

    Eskander, R.; Lee, J. Y.; Mirza, M.; Lorusso, D.; Mackay, H.; Ray-Coquard, I.; Oaknin, A.; Gonzalez-Martin, A.; Hasegawa, K.; Corr, B.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • BIO25-027: Addressing early diagnosis challenges: Utilizing C the Signs clinical decision support platform for pancreatic cancer risk assessment
    Meeting Abstract

    Raoof, S.; Dadhania, S.; Patel, T.; Herrick, B.; Bakshi, B.; Payling, M.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • TIP25-244: Comprehensive Outcomes for After Cancer Health (COACH) Study: 2024 trial in progress updates
    Meeting Abstract

    Brassil, K.; Halpenny, B.; Arthur, E.; Swartz, M. C.; Kaler, A.; Krok-Schoen, J.; Lally, R.; Loftis, J.; Saligan, L.; Schmidt, R.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save